Sequestration of oxidative is necessary but not sufficient enough to conclude dopaminergic neuroprotective efficacy of curcumin: Insights from ALSS Drosophila Parkinson disease model

Limamanen Phom,Priyanka Modi,Abhik Das,Sarat Chandra Yenisetti

DOI: https://doi.org/10.1101/2024.09.19.613867

2024-09-20

Abstract:Turmeric is a centuries-old ethnomedicine in Asia. Previously our laboratory demonstrated in the adult life stage-specific (ALSS) Drosophila model of Parkinson disease (PD) that Curcumin (K)-mediated dopaminergic (DAergic) neuroprotection is absent in the transition stage of adult life during which late-onset neurodegenerative disorders like PD sets-in, suggesting its limitation as a therapeutic agent. The present study demonstrates that K can sequester the enhanced levels of brain oxidative stress (OS) during both adult life phases i.e. health and transition stages but confers neuroprotection only during the health phase. However, literature reviews illustrate that efficacy of supposed therapeutic agents was asserted by their ability to sequester OS in only young PD animal models. In this context, it is important to point out that despite encouraging results in animal models, therapeutic efforts to target the general state of OS failed to retard PD progression. To understand this paradigm, we further investigated ALSS regulation of molecular players in the brain of the ALSS fly PD model and discovered that K-mediated differential modulation of adaptive stress response through dFOXO contributes to health phase-specific neuroprotection. These observations suggest that apart from the study of OS markers; it is essential to understand the ALSS regulation of molecular players. The synergistic influence of OS and the ALSS dysfunctional molecular networks could be responsible for the DAergic neurodegeneration in PD. The insights suggest that sequestration of OS by a therapeutic agent is necessary, but inadequate to conclude its neuroprotective efficacy and push it to the next phase of preclinical/clinical evaluation.

Neuroscience

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to evaluate the scavenging ability of curcumin (K) against oxidative stress (OS) in the Drosophila model of Parkinson's disease (PD) and its effectiveness in dopaminergic neuroprotection. Specifically, the researchers focused on the following points:

1. **The scavenging effect of curcumin on oxidative stress**:
- Studies have shown that curcumin can effectively scavenge oxidative stress markers in the brain, such as reactive oxygen species (ROS), malondialdehyde (MDA), protein carbonyls (PC), and hydroperoxides (HP), during the healthy adult stage and the transition stage (i.e., the stage when Parkinson's disease begins to occur).

2. **The neuroprotective effect of curcumin**:
- Although curcumin can scavenge oxidative stress, its neuroprotective effect is only significant during the healthy adult stage and not obvious during the transition stage. This indicates that relying solely on the scavenging of oxidative stress markers to evaluate the neuroprotective effect of drugs is not sufficient.

3. **Exploration of molecular mechanisms**:
- The study further explored the mechanism by which curcumin achieves neuroprotective effects by regulating dFOXO, a key transcription factor in the adaptive stress response. The results showed that curcumin up - regulates the expression of dFOXO during the healthy adult stage, thereby enhancing neuroprotective effects, but this up - regulation disappears during the transition stage.

4. **Clinical significance**:
- These findings emphasize that when evaluating the neuroprotective effects of potential therapeutic drugs, in addition to examining their impact on oxidative stress markers, it is also necessary to consider the life - stage - specific regulatory molecular networks. This helps to explain why some drugs that show good effects in animal models fail to achieve the expected results in clinical trials.

In conclusion, through detailed research, this paper reveals the neuroprotective effects of curcumin on Drosophila models of Parkinson's disease at different life stages and proposes the importance of comprehensively considering multiple factors when evaluating drug efficacy.